South Korea · Delayed Price · Currency is KRW Curocell Statistics
Total Valuation
Curocell has a market cap or net worth of KRW 438.51 billion. The enterprise value is 470.50 billion.
| Market Cap | 438.51B |
| Enterprise Value | 470.50B |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Curocell has 15.23 million shares outstanding. The number of shares has increased by 2.25% in one year.
| Current Share Class | 15.23M |
| Shares Outstanding | 15.23M |
| Shares Change (YoY) | +2.25% |
| Shares Change (QoQ) | +1.76% |
| Owned by Insiders (%) | 35.16% |
| Owned by Institutions (%) | 5.43% |
| Float | 9.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 17.88 |
| P/TBV Ratio | 20.78 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.36, with a Debt / Equity ratio of 1.96.
| Current Ratio | 0.36 |
| Quick Ratio | 0.24 |
| Debt / Equity | 1.96 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.49 |
| Interest Coverage | -7.26 |
Financial Efficiency
Return on equity (ROE) is -203.85% and return on invested capital (ROIC) is -29.83%.
| Return on Equity (ROE) | -203.85% |
| Return on Assets (ROA) | -23.50% |
| Return on Invested Capital (ROIC) | -29.83% |
| Return on Capital Employed (ROCE) | -118.41% |
| Weighted Average Cost of Capital (WACC) | 7.65% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -6.84% in the last 52 weeks. The beta is 0.60, so Curocell's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | -6.84% |
| 50-Day Moving Average | 46,248.00 |
| 200-Day Moving Average | 44,706.25 |
| Relative Strength Index (RSI) | 25.89 |
| Average Volume (20 Days) | 140,675 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -17.43M |
| Operating Income | -37.85B |
| Pretax Income | -48.20B |
| Net Income | -48.20B |
| EBITDA | -31.65B |
| EBIT | -37.85B |
| Earnings Per Share (EPS) | -3,337.30 |
Balance Sheet
The company has 16.20 billion in cash and 48.19 billion in debt, with a net cash position of -31.99 billion or -2,101.16 per share.
| Cash & Cash Equivalents | 16.20B |
| Total Debt | 48.19B |
| Net Cash | -31.99B |
| Net Cash Per Share | -2,101.16 |
| Equity (Book Value) | 24.53B |
| Book Value Per Share | 1,671.01 |
| Working Capital | -43.96B |
Cash Flow
In the last 12 months, operating cash flow was -31.98 billion and capital expenditures -363.39 million, giving a free cash flow of -32.35 billion.
| Operating Cash Flow | -31.98B |
| Capital Expenditures | -363.39M |
| Depreciation & Amortization | 6.19B |
| Net Borrowing | 9.46B |
| Free Cash Flow | -32.35B |
| FCF Per Share | -2,124.51 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Curocell does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.25% |
| Shareholder Yield | -2.25% |
| Earnings Yield | -10.99% |
| FCF Yield | -7.38% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |